Lower esophageal sphincter inflammation/gastroesophageal reflux disease Gastroesophageal reflux disease (GERD) occurs as a result of pathological regurgitation of stomach contents into the esophagus
A large portion of what shows up on your report may not be usable by your cells
Regulatory and safety status: It's pending FDA review and not currently approved for use in humans
Back Unger, RH, Eisentraut, AM, Madison et al (1959) 'Glucagon antibodies and their use for immunoassay for glucagon', Experimental Biology and Medicine , 102/3
The corresponding pharmacokinetic parameters are listed as follows: T max = 0.167 h, C max = 155 11.8 ng Eq./ml, AUC 0t = 4945 417 h ng Eq./ml, AUC 0 = 12956 2074 hng Eq./ml, average residence time (MRT 0-t ) of plasma total radioactivity = 33.2 1.03 h, and t 1/2 = 102 h (Table 9)